| Succinate Forms and Compositions of Bruton's Tyrosine Kinase Inhibitors |
2023-1-18 |
2023-4-11 |
|
| Pyrimidinyl tyrosine kinase inhibitors |
2023-1-16 |
2023-4-11 |
|
| Hdac inhibitor solid state forms |
2022-12-13 |
2023-5-25 |
|
| Histone deacetylase inhibitors for use in immunotherapy |
2022-11-18 |
2023-5-18 |
|
| Heterocyclic compounds useful as PDK1 inhibitors |
2022-11-04 |
2023-1-10 |
|
| Combination of car t-cell therapy with btk inhibitors and methods of use … |
2022-11-02 |
2023-5-11 |
|
| Vecabrutinib for the treatment of graft-versus-host disease |
2022-11-02 |
2023-5-11 |
|
| Heterocyclic pdk1 inhibitors for use to treat cancer |
2022-6-02 |
2023-3-30 |
|
| Bruton's tyrosine kinase inhibitors |
2022-5-12 |
2023-2-16 |
|
| Pharmaceutical formulations, processes for preparation, and methods of use |
2022-1-18 |
2022-5-05 |
|
| Methods and compositions for treating viral or virally-induced conditions |
2021-12-08 |
2022-8-11 |
|
| Hdac inhibitor solid state forms |
2020-12-04 |
2021-9-16 |
|
| Dosages for hdac treatment with reduced side effects |
2020-10-06 |
2021-4-15 |
|
| Methods of treating virally associated cancers with histone deacetylase … |
2020-7-08 |
2021-3-23 |
2021-3-23 |
| Methods of treating virally associated cancers with histone deacetylase … |
2020-5-28 |
2020-12-03 |
|
| Stable sns-595 compositions and methods of preparation |
2019-7-02 |
2019-7-18 |
|
| Biaryl compounds useful for treatment of human diseases in oncology, neurology … |
2019-5-07 |
2019-9-26 |
|
| Epigenetic modifiers for use in cellular immunotherapy |
2019-1-11 |
2021-10-06 |
|
| Sns-595 and methods of using the same |
2018-4-27 |
2018-11-01 |
|
| Stable sns-595 compositions and methods of preparation |
2018-4-11 |
2019-3-21 |
|
| Methods of treatment using pyridinonyl pdk1 inhibitors |
2018-1-22 |
2018-12-27 |
|
| Inhibitors of bruton's tyrosine kinase |
2018-1-19 |
2018-10-11 |
|
| Chemical synthesis |
2018-1-12 |
2018-8-23 |
|
| Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1- … |
2017-9-25 |
2018-4-12 |
|
| Combined use of (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1- … |
2017-8-03 |
2017-12-28 |
|
| Method of preparing (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1- … |
2017-7-06 |
2017-12-07 |
|
| Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1- … |
2017-7-05 |
2017-12-28 |
|
| Substituted pyrimidines for inhibiting Raf kinase activity |
2016-12-15 |
2018-3-20 |
2018-3-20 |
| Sns-595 and methods of using the same |
2016-10-31 |
2016-11-17 |
|
| Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1- … |
2016-9-29 |
2017-2-09 |
|
| Methods of using sns-595 for treatment of cancer subjects with reduced brca2 … |
2016-8-10 |
2017-6-29 |
|
| Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1- … |
2016-8-03 |
2016-8-18 |
|
| METHODS OF USING (+)-1,4-DIHYDRO-7-[(3s,4s)-3-METHOXY-4-(METHYLAMINO)-1- … |
2016-8-03 |
2016-8-18 |
|
| Compounds and compositions for treatment of cancer |
2016-5-16 |
2017-4-13 |
|
| Heterocyclic tyrosine kinase inhibitors |
2016-2-29 |
2017-2-02 |
|
| Sns-595 and methods of using the same |
2015-1-09 |
2015-4-23 |
|
| METHODS OF USING (+)-1,4-DIHYDRO-7-[(3s,4s)-3-METHOXY-4-(METHYLAMINO)-1- … |
2014-12-18 |
2015-1-22 |
|
| Biaryl compounds useful for the treatment of human diseases in oncology, … |
2014-12-11 |
2019-5-20 |
2019-5-20 |
| Pyrimidine Derivatives Useful as Raf Kinase Inhibitors |
2014-1-03 |
2014-1-23 |
|
| Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1- … |
2013-8-23 |
2016-9-22 |
2016-9-22 |
| Stable sns-595 compositions and methods of preparation |
2013-4-05 |
2015-7-23 |
2015-7-23 |
| Sns-595 and methods of using the same |
2013-2-27 |
2015-4-23 |
2015-4-23 |
| Methods for ligand discovery |
2013-2-21 |
2013-6-13 |
|
| Method for ligand discovery |
2011-2-25 |
2011-7-21 |
|
| Methods and low dose regimens for treating red blood cell disorders |
2010-12-08 |
2013-12-31 |
2013-12-31 |
| Compounds and methods for treatment of cancer |
2010-10-26 |
2011-5-05 |
|
| Heteroaryl btk inhibitors |
2010-9-03 |
2012-8-15 |
|
| Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as … |
2010-7-26 |
2011-3-10 |
|
| Detection of short-chain fatty acids in biological samples |
2010-7-12 |
2011-2-10 |
|
| Heteroaryl compounds useful as Raf kinase inhibitors |
2009-12-30 |
2011-8-04 |
|
| Thienopyrimidines useful as aurora kinase inhibitors |
2009-10-08 |
2010-7-15 |
|
| Aurora kinase inhibitors |
2009-3-16 |
2010-12-29 |
|
| Methods for identifying compounds that modulate enzymatic activity |
2008-11-20 |
2008-12-11 |
|
| Heterocyclic compounds useful as RAF kinase inhibitors |
2008-6-30 |
2011-6-28 |
2011-6-28 |
| Weight Loss Treatment |
2008-5-23 |
2008-11-27 |
|
| Tetrahydro-pyrazolo-pyridine thioether modulators of cathepsin s |
2008-2-14 |
2009-4-16 |
|
| Monocyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
2008-2-14 |
2009-5-07 |
|
| Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
2008-2-14 |
2008-10-30 |
|
| Biaryl-substituted tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
2008-2-14 |
2008-8-28 |
|
| Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
2008-2-14 |
2008-8-21 |
|
| Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's … |
2007-9-04 |
2008-3-13 |
|
| Pharmaceutical dosage forms for (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-( … |
2007-8-01 |
2010-2-25 |
|
| Methods for treating blood disorders |
2007-5-09 |
2009-7-22 |
|
| Aurora expression constructs |
2007-1-03 |
2008-1-24 |
|
| Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1- … |
2006-9-05 |
2008-10-29 |
|
| Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1- … |
2006-9-05 |
2007-3-08 |
|
| Therapeutic combinations comprising (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-( … |
2006-9-05 |
2015-9-02 |
|
| Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1- … |
2006-9-05 |
2007-3-08 |
|
| Substituted pyrazolo[4,3-d]pyrimidines as aurora kinase inhibitors |
2006-7-21 |
2011-4-26 |
2011-4-26 |
| Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's … |
2006-7-14 |
2011-8-25 |
2011-8-25 |
| Histone Deacetylase Inhibitors |
2006-5-15 |
2010-6-17 |
|
| Extended tethering approach for rapid identification of ligand |
2005-12-13 |
2006-4-27 |
|
| Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment … |
2005-10-12 |
2010-3-31 |
|
| Thienopyrimidines useful as aurora kinase inhibitors |
2005-7-15 |
2008-4-09 |
|
| An extended tethering approach for rapid identification of ligands |
2005-7-13 |
2005-8-04 |
|
| Constructs for homogenously processed preparations of beta site APP-cleaving … |
2004-7-20 |
2006-1-26 |
|
| Aspartyl protease inhibitors |
2003-12-10 |
2006-10-03 |
2006-10-03 |
| Aspartyl protease inhibitors |
2003-12-10 |
2005-1-20 |
|
| Constructs homogenously processed preparations of beta site app-cleaving enzyme |
2003-12-02 |
2004-7-14 |
|
| Constructs for homogenously processed preparations of beta site APP-cleaving … |
2003-12-02 |
2005-4-07 |
|
| Identification of kinase inhibitors |
2003-9-17 |
2006-6-21 |
|
| Identification of kinase inhibitors |
2003-9-17 |
2005-4-21 |
|
| Aspartyl protease inhibitors |
2003-6-16 |
2005-3-23 |
|
| Caspase-1 inhibitors and methods for their use |
2003-6-05 |
2004-3-11 |
|
| Methods for identifying allosteric sites |
2003-4-08 |
2003-10-23 |
|
| Methods of characterizing molecular interaction sites on proteins |
2003-4-04 |
2003-10-27 |
|
| Identification of kinase inhibitors |
2003-3-20 |
2003-10-08 |
|
| Compounds that modulate the activity of ptp-1b and tc-ptp |
2003-2-26 |
2003-9-12 |
|
| Small molecule modulators of apoptosis |
2003-2-11 |
2003-9-04 |
|
| Surface plasmon resonance methods |
2003-1-29 |
2003-10-02 |
|
| Small-molecule inhibitors of interleukin-2 |
2002-12-17 |
2003-6-30 |
|
| Small molecule inhibitors of caspases |
2002-9-17 |
2003-4-01 |
|
| Small molecule inhibitors of caspases |
2002-9-17 |
2005-4-12 |
2005-4-12 |
| Process for the production of an immunosuppressant |
2002-8-29 |
2006-10-17 |
2006-10-17 |
| Cysteine mutants and methods for detecting ligand binding to biological … |
2002-8-05 |
2003-2-24 |
|
| Cysteine mutants and methods for detecting ligand binding to biological … |
2002-8-05 |
2003-2-20 |
|